Trelegy ellipta and Confusional state - a phase IV clinical study of FDA data
Summary:
Confusional state is reported as a side effect among people who take Trelegy ellipta (fluticasone furoate; umeclidinium bromide; vilanterol trifenatate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aspirin, and have Chronic obstructive pulmonary disease.
The phase IV clinical study analyzes which people have Confusional state when taking Trelegy ellipta. It is created by eHealthMe based on reports of 27,966 people who have side effects when taking Trelegy ellipta from the FDA, and is updated regularly.
What is Trelegy ellipta?
Trelegy ellipta has active ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 28,101 Trelegy ellipta users. Check the latest studies of Trelegy ellipta.
What is Confusional state?
Confusional state is found to be associated with 2,720 drugs and 3,320 conditions by eHealthMe. Check the latest studies of Confusional state.
27,966 people reported to have side effects when taking Trelegy ellipta.
Among them, 102 people (0.36%) have Confusional state.
Among these 102 people:
How long have people been on Trelegy ellipta when they have Confusional state? *
What is the gender of people who have Confusional state when taking Trelegy ellipta? *
What is the age of people who have Confusional state when taking Trelegy ellipta? *
What are other drugs people take besides Trelegy ellipta? *
What are other side effects people have besides Confusional state? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Trelegy ellipta and have Confusional state?
- Check whether Confusional state is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Trelegy ellipta:
- Trelegy ellipta (28,101 reports)
Confusional state treatments and more:
- Confusional state (182,510 reports)
How severe was Confusional state and when was it recovered:
Expand to all the drugs that have ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate:
- Confusional state and drugs with ingredients of fluticasone furoate; umeclidinium bromide; vilanterol trifenatate (105 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Trelegy ellipta:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Confusional state:
- Confusional state (2,720 drugs)
Browse all the conditions that are associated with Confusional state:
- Confusional state (3,320 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on fluticasone furoate; umeclidinium bromide; vilanterol trifenatate (the active ingredients of Trelegy ellipta) and Trelegy ellipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Prednisolone cause Bleeding Disorders? - a second ago
- Hypokalemia and drugs of ingredients of pyrazinamide - 6 seconds ago
- Could Viorele cause Fatigue? - 12 seconds ago
- Could Avodart cause Muscle Atrophy? - 14 seconds ago
- Acne and drugs of ingredients of rifaximin - 16 seconds ago
- Mirena and Discharge From The Vagina for Women aged 50-59 - 24 seconds ago
- Mirena and Vaginal Discharge for Women aged 50-59 - 24 seconds ago
- Drug interactions of Finasteride and Azilect - 25 seconds ago
- Sleep Apnea Syndrome and drugs of ingredients of magnesium hydroxide; omeprazole; sodium bicarbonate - 32 seconds ago
- Oral Administration Complication and drugs of ingredients of mesalamine - 46 seconds ago